TELA Bio, Inc. announced on June 3, 2025, the launch of its OviTex Inguinal Reinforced Tissue Matrix in Europe. TELA Bio—which was founded in 2012 and is headquartered in Pennsylvania—is a medical ...
Nexture Bio has acquired Matrix F.T. Nexture Bio plans to make its expanded portfolio of high-performing adherent cell culture products available to a global range of customers and partners, including ...
Nanoscribe and Advanced BioMatrix have joined forces to pioneer the field of bioprinting with the launch of four advanced bioresins tailored for Two-Photon Polymerization (2PP) based 3D printing. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results